• Home
  • >
  • Titan Biotech Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/titan-biotech-ltd.png Logo

Titan Biotech Ltd Financial Statement

Titan Biotech Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue46.4243.9835.03
Operating Expense35.3834.7126.86
Net Profit7.386.035.41
Net Profit Margin15.913.7115.44
Earning Per Share8.937.36.55
EBIDTA11.019.248.17
Effective Tax Rate23.0122.3320.44

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Titan Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual144123.55142.24
Operating Expenses Annual114.4892.2896.11
Operating Profit Annual31.4632.2146.59
Interest Annual0.750.871.67
Depreciation2.572.352.22
Net Profit Annual24.8421.6830.34
Tax Annual7.097.2811

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Titan Biotech Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning6.815.311.83
Cash Flow from Operations21.1822.0419.08
Cash Flow from Investing-20.73-16.44-4.86
Cash Flow from Financing-2.4-4.1-10.6
Cash Flow at the End4.866.815.45

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Titan Biotech Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)21.8526.0732.8
PBIT Margin (%)20.0524.1531.24
PBT Margin (%)-6.67-3.610.26
Net PROFIT Margin (%)14.617.5523.49
Return On Networth / Equity (%)21.4327.9858.75
Return On Networth /Employed(%)26.6432.6659.1
Return On Assets (%)19.4123.3442.76
Total Debt / Equity(X)0.090.130.27
Asset Turnover Ratio (%)1.331.331.82

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Titan Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual35.8934.9933.61
Total Current Assets Annual68.3163.7658.83
Non Current Assets Annual66.2144.3441.89
Total Shareholders Funds Annual109.9186.2468.76
Total Assets Annual134.52108.09100.72

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Titan Biotech Ltd Earning Calls
Dec 2023
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Titan Biotech Ltd has a market capitalization of 162.67 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Titan Biotech Ltd is debt-free with a debt-to-equity ratio of 0.08.

In FY 2023, Titan Biotech Ltd recorded a total revenue of approximately 144 Cr marking a significant milestone in the company's financial performance.

Titan Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and 0.0% annually, respectively..

Titan Biotech Ltd's current PE ratio is 6.55.

Titan Biotech Ltd's ROCE averaged 37.1% from the FY ending March 2021 to 2023, with a median of 33.9%. It peaked at 53.1% in March 2021, reflecting strong capital efficiency over the period..

Titan Biotech Ltd's latest EBIT is Rs. 28.87 Cr, surpassing the average EBIT of Rs. 37.58 Cr over the 5 years..